News

Filter

Current filters:

ZetiaMylan Laboratories

101 to 110 of 96158 results

FDA Advisory votes against approving Actavis nebivolol/valsartan combo

FDA Advisory votes against approving Actavis nebivolol/valsartan combo

10-09-2014

Ireland-based generic drug major Actavis yesterday confirmed that the US Food and Drug Administration's…

ActavisCardio-vascularnebivololPharmaceuticalRegulationUSAvalsartan

Oliver Siegel appointed chief operating officer at AFFiRiS

Oliver Siegel appointed chief operating officer at AFFiRiS

09-09-2014

Oliver Siegel has been appointed as chief operating officer at Austrian vaccine specialist AFFiRiS AG,…

AFFiRiSAustriaBoardroomChronic diseasesOliver SiegelPharmaceuticalVaccine specialist

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

09-09-2014

UK pharma giant GlaxoSmithKline today announced a £5 million ($8.2 million) collaboration with the UK…

FinancialGlaxoSmithKlinePharmaceuticalResearchSouth AfricaUK

Gilead's monopoly in HIV therapies to be toppled by Viiv's Triumeq; report

Gilead's monopoly in HIV therapies to be toppled by Viiv's Triumeq; report

09-09-2014

The recent US Food and Drug Administration and European Commission approval of HIV specialist ViiV Healthcare’s…

Anti-viralsAtriplaBiotechnologyGilead SciencesGlobalDataHIVMarkets & MarketingStribildTriumeqUSAViiV Healthcare

Value of patents as enabling and supporting medical research stressed by AusBiotech

09-09-2014

Patents are at the core of enabling genetic tests, treatments, vaccines and cures resulting from medical…

AustraliaBiotechnologyPatentsResearch

101 to 110 of 96158 results

Back to top